AMWL Stock Recent News

While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

American Well Corporation (NYSE:AMWL ) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbaugh - Morgan Stanley Jack Wallace - Guggenheim Securities Matthew Shea - Needham & Company Jenny Cao - Truist Securities Jessica Tassan - Piper Sandler David - from BTIG Charles Rhyee - TD Cowen Operator Good afternoon. My name is Rob, and I will be your conference operator today.

Telehealth provider Amwell on Wednesday (July 31) reported second-quarter revenue of $62.8 million (above guidance of $61.1 million), driven by $27.5 million in subscription revenue and $28.7 million from visits to Amwell Medical Group (AMG). Despite a net loss of $49.9 million — down from $73.

American Well Corporation (AMWL) came out with a quarterly loss of $3.36 per share versus the Zacks Consensus Estimate of a loss of $3.94. This compares to loss of $4.60 per share a year ago.

Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the second quarter 2024 earnings report.

American Well (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31.

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company's Class A common stock are expected to begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis at the market open on July 11, 2024. No change will be made to the trading symbol for the Company's shares of Class A common stock, “AMWL”, in connection with the Reverse Split.

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13.

Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility